Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Malaria is a leading cause of death and illness around the world. Over 200 million cases are reported every year, and more than 400 000 people die. More than 90% of cases are reported in sub-Saharan Africa. Scientists have spent decades searching for an effective vaccine. Hence the recent excitement when Malawi’s government announced it had launched a pilot programme for the world’s first malaria vaccine, RTS,S (also known as Mosquirix©), produced by the pharmaceutical company, GSK. It’s the first vaccine to demonstrate significant reduction in malaria in children. The Conversation Africa’s Ina Skosana asked immunologist Faith Osier about RTS,S.

The Conversation logo

Engaging youth in health and research in rural Cambodia: a qualitative study.

Journal article

Ean M. et al, (2026), Global health action, 19

The coronaviral landscape across diverse mammalian species in the Northeastern United States

Journal article

Ibemgbo S. et al, (2026), Scientific Reports, 16

Seasonal dynamics and control of malaria: A non-autonomous model incorporating vaccination and drug resistance

Journal article

Onah IS., (2026), Nonlinear Analysis: Real World Applications, 91, 104584 - 104584

A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment

Journal article

Donovan J. et al, (2026), Journal of Infection, 93, 106796 - 106796

A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam

Journal article

Thi HN. et al, (2026), International Journal of Infectious Diseases, 168, 108673 - 108673

Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025

Journal article

Dhawan S. et al, (2026), Journal of Infection, 93, 106766 - 106766

A case of gastrointestinal tuberculosis in a 3-mo-old infant with profound immunodeficiency.

Journal article

Karanja-Chege C. et al, (2026), Journal of human immunity, 2

Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda

Journal article

Maitland K. et al, (2026), New England Journal of Medicine

Load More